Kronus Inc is a pioneering provider of immunodiagnostic reagents and test kits, offering innovative solutions and exceptional customer support. Since 1986, the company has been at the forefront of the research and clinical laboratory marketplace, developing a reputation for delivering unique and top-quality products. Their collaboration with leading research and developmental scientists underscores their commitment to innovation and excellence.
Specializing in over a dozen immunoassay test kits and related laboratory reagents, Kronus Inc plays a crucial role in the assessment of various autoimmune disorders. With a clear focus on empowering medical research, the company's impact on the pharmaceutical industry is significant.
Although specific details regarding headquarters location and recent investment information are not available at this time, Kronus Inc continues to make strides in advancing immunodiagnostic solutions, positioning itself as an attractive prospect for future investors looking to align with innovation and excellence in the medical research sector.
